Information about Betramin
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0427.475.040

VAT liability
Yes
Established
21-06-1985
Last balance sheet year
2024
Company size
Big 0 FTE
Commercial name
BETRAMIN NV
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Betramin

2024 2023 2022 2021
Profit/Loss € 3,802,965 22 % € 3,107,839 4 % € 2,974,741 31 % € 2,271,889
Equity € 28,617,928 15 % € 24,814,963 12 % € 22,078,110 16 % € 19,103,369
Gross margin € 407,453 -1 % € 410,273 -55 % € 921,327 184 % € 324,099

Publications from Betramin

Date Publication
03-03-2025 Capital - Shares (NL)
08-06-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Resignations - Appointments (NL)
07-03-2018 Registered Office (NL)
26-07-2017 Resignations - Appointments (NL)
06-08-2014 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)

Frequently asked questions

What is the VAT number of Betramin?
The VAT number of Betramin is BE 0427.475.040.
Wat is the PEPPOL ID of Betramin?
The PEPPOL ID of Betramin is 0208:0427475040. Log in or start a free trial to see the full overview.
When was Betramin founded?
Betramin was founded on 21-06-1985.
What is the address of Betramin?
The current registered office of Betramin is located at Burgemeester Vandenbogaerdelaan 40, 8870 Izegem.
When was the last time Betramin filed their annual financial statements?
The most recent financial statements of Betramin were filed on 25-07-2025.
How many employees does Betramin have?
There are currently no employees working at Betramin or no workforce information is available.
What is the annual turnover of Betramin?
At the time of its most recent financial statements, Betramin did not publish any turnover figures. Betramin reported a gross margin of €407,452.72.

Sources